Applications of high-resolution clone tracking technologies in cancer.

cell barcoding clonality lineage tracing single cell transcriptomics tumor heterogeneity

Journal

Current opinion in biomedical engineering
ISSN: 2468-4511
Titre abrégé: Curr Opin Biomed Eng
Pays: England
ID NLM: 101704011

Informations de publication

Date de publication:
Sep 2021
Historique:
entrez: 13 12 2021
pubmed: 14 12 2021
medline: 14 12 2021
Statut: ppublish

Résumé

Tumors are comprised of dynamic, heterogenous cell populations characterized by numerous genetic and non-genetic alterations that accumulate and change with disease progression and treatment. Retrospective analyses of tumor evolution have relied on the measurement of genetic markers (such as copy number variants) to infer clonal dynamics. However, these approaches neglect the critical contributions of non-genetic drivers of disease. Techniques that harness the power of prospective clone tracking via heritable barcode tags provide an alternative strategy. In this review, we discuss methods for high-resolution, quantitative clone tracking, including recent advancements to pair barcode-specific functionality with scRNA-seq, clonal cell isolation, and in situ hybridization and imaging. We discuss these approaches in the context of cancer cell heterogeneity and treatment resistance.

Identifiants

pubmed: 34901584
doi: 10.1016/j.cobme.2021.100317
pmc: PMC8658740
mid: NIHMS1760042
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R21 CA212928
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA253540
Pays : United States

Références

Nat Genet. 2021 Jan;53(1):76-85
pubmed: 33398196
Science. 2016 Jul 29;353(6298):aaf7907
pubmed: 27229144
Nat Methods. 2017 Mar;14(3):297-301
pubmed: 28099430
Nat Methods. 2017 Feb;14(2):195-200
pubmed: 27918539
Genome Biol. 2014 May 30;15(5):R75
pubmed: 24886633
Nat Biotechnol. 2021 Jul;39(7):865-876
pubmed: 33619394
Science. 2016 Sep 9;353(6304):
pubmed: 27540006
Nat Rev Genet. 2019 May;20(5):257-272
pubmed: 30696980
Science. 2018 Aug 31;361(6405):
pubmed: 30093604
Genome Biol. 2016 Apr 15;17:69
pubmed: 27083415
Nature. 2020 Jul;583(7817):585-589
pubmed: 32669716
BMC Biol. 2020 Nov 24;18(1):177
pubmed: 33234154
Nat Commun. 2019 Mar 15;10(1):1234
pubmed: 30874552
Science. 2021 Feb 26;371(6532):
pubmed: 33479121
Nature. 2019 Jun;570(7759):77-82
pubmed: 31086336
Nature. 2017 Jan 5;541(7635):107-111
pubmed: 27869821
Science. 2019 Apr 26;364(6438):
pubmed: 30898844
Nature. 2014 Oct 16;514(7522):322-7
pubmed: 25296256
Genome Biol. 2016 Nov 25;17(1):239
pubmed: 27887629
Nat Protoc. 2020 Mar;15(3):750-772
pubmed: 32051617
Nat Protoc. 2019 Jun;14(6):1820-1840
pubmed: 31110297
Nat Biotechnol. 2018 Jun;36(5):469-473
pubmed: 29644996
Nat Med. 2015 May;21(5):440-8
pubmed: 25849130
Science. 2018 Jun 1;360(6392):981-987
pubmed: 29700229
Nat Rev Genet. 2009 May;10(5):336-42
pubmed: 19337290
Genome Res. 2010 Jan;20(1):68-80
pubmed: 19903760
ACS Synth Biol. 2018 Oct 19;7(10):2468-2474
pubmed: 30169961
Nat Commun. 2019 Feb 15;10(1):766
pubmed: 30770823
Science. 2020 Feb 14;367(6479):
pubmed: 31974159
Nat Biotechnol. 2021 Feb;39(2):174-178
pubmed: 32719478
Genome Biol. 2019 May 9;20(1):90
pubmed: 31072405
Nature. 2018 Apr 5;556(7699):108-112
pubmed: 29590089
Breast Cancer Res. 2020 Jun 23;22(1):68
pubmed: 32576280
Nature. 2016 Apr 20;533(7603):420-4
pubmed: 27096365
Nature. 2011 Apr 7;472(7341):90-4
pubmed: 21399628
Nature. 2014 Aug 14;512(7513):155-60
pubmed: 25079324
Genome Biol. 2013 Jul 03;14(7):405
pubmed: 23822731
Cancer Metastasis Rev. 2016 Dec;35(4):547-573
pubmed: 28025748
Nat Protoc. 2018 Nov;13(11):2685-2713
pubmed: 30353175
Nat Biotechnol. 2018 Nov 12;:
pubmed: 30418433
Nat Chem Biol. 2021 Jun;17(6):739-747
pubmed: 33753928
PLoS Comput Biol. 2005 Oct;1(5):e50
pubmed: 16261192
Nat Med. 2014 Apr;20(4):344-6
pubmed: 24710378
Biomark Res. 2019 Oct 31;7:23
pubmed: 31695915
Nature. 2017 Aug 24;548(7668):456-460
pubmed: 28813413
Phys Biol. 2020 Nov 20;18(1):016001
pubmed: 33215611
Nature. 2018 Jan 11;553(7687):212-216
pubmed: 29323290

Auteurs

Daylin Morgan (D)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, 78712, United States.

Tyler A Jost (TA)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, 78712, United States.

Carolina De Santiago (C)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, 78712, United States.

Amy Brock (A)

Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, 78712, United States.

Classifications MeSH